Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. (Q34543319)

2 August 2017

Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19. (English)

1 reference

2 August 2017

1 reference

John G Gerber

1

1 reference

PubMed ID

14628297

2 August 2017

Robert J Rhodes

series ordinal

2

1 reference

PubMed ID

14628297

2 August 2017

Joseph Gal

series ordinal

3

1 reference

2 August 2017

1 January 2004

1 reference

2 August 2017

1 reference

2 August 2017

16

1 reference

2 August 2017

1

1 reference

2 August 2017

36-44

1 reference

The biotransformation of methadone in man: synthesis and identification of a major metabolite.

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

The medical status of methadone maintenance patients in treatment for 11-18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Clinical effects and pharmacokinetics of racemic methadone and its optical isomers

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

The role of CYP2B6 in human xenobiotic metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Development of validated stereoselective methods for methadone determination in clinical samples.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Lack of a pharmacologic interaction between rifabutin and methadone in HIV-infected former injecting drug users.

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

In vivo modulation of CYP enzymes by quinidine and rifampin

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Pharmacokinetic Interaction between amprenavir and rifabutin or rifampin in healthy males

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Rifampin-Induced Methadone Withdrawal

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

The effect of fluconazole on the clinical pharmacokinetics of methadone

1 reference

https://api.crossref.org/works/10.1002%2FCHIR.10303

7 January 2021

Identifiers

DOI

10.1002/CHIR.10303

1 reference

2 August 2017

1 reference

PubMed ID

14628297